Bone: Bone density screening leads to reduced fracture risk

Nature Reviews Endocrinology

Volumn 6, Issue 1, 2010, Pages 17-18

  Watts, Nelson B ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

BONE DENSITY; BONE MASS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; OSTEOPENIA; PATIENT ASSESSMENT; PATIENT MONITORING; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST; SHORT SURVEY; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, BONE; HEALTH PLANNING GUIDELINES; HUMANS; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS; UNITED STATES;

EID: 73949155113     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.246     Document Type: Short Survey

References (9)

1. Marshall, D., Johnell, O. & wedel, H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312, 1254-1259 (1996).
2. Delmas, P. D. Treatment of postmenopausal osteoporosis. Lancet 359, 2018-2026 (2002).
3. Barr, R. J., stewart, A., Torgerson, D. J. & Reid, D. A. Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos. Int. doi:10.1007/s00198-009-1007-x.
4. Food and Drug Administration. Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis [online], http://www.fda.gov/downloads/scienceResearch/ specialTopics/womensHealthResearch/ UCM131206.pdf (1994).
5. Us Preventive services Task Force. screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann. Intern. Med. 137, 526-528 (2002).
6. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. national Osteoporosis Foundation [online], http://www.natap.org/ 2008/Hiv/nOF-Clinicians-Guide-1.pdf. (2008).
7. Dell, R., Green, D., Schelkun, S. R. & Williams, K. Osteoporosis disease management: the role of the orthopedic surgeon. J. Bone Joint Surg. Am. 90 (suppl. 4), 188-194 (2008).
8. Newman, E. D., Ayoub, W. T. , Starkey, R. H., Diehl, J. M. & Wood, G. C. Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenpausal women after 5 years. Osteoporos. Int. 14, 146-151 (2003).
9. Kanis, J. A. & World Health Organization scientific Group. Assessment of Osteoporosis at the Primary Healthcare Level (wHO, sheffield, 2007).